Navigation Links
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
Date:8/6/2009

CARLSBAD, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced its financial results for the quarter ended June 30, 2009. During 2009 Isis has continued to successfully execute its business strategy and as a result reported $669,000 of pro forma net income for the quarter ended June 30, 2009, a significant improvement over the same period in 2008. Isis also reported a pro forma net operating loss of $1.3 million for the second quarter compared to pro forma net operating income of $4.6 million for the same period in 2008. Maintaining its strong cash position, Isis ended the quarter with $637.5 million of cash and remains on track to end 2009 with more than $550 million of cash. Isis also remains on track to meet its guidance of more than $145 million of pro forma net income and a pro forma net operating loss in the low to mid $20 million range, in both cases excluding non-cash stock compensation expense.

"Our strong financial performance is a direct result of the success of our technology platform and business strategy. We and our partners are advancing our large and growing pipeline of 19 drugs in development. Our partnership strategy not only allows our drugs to move forward effectively toward the market but also provides us with significant short and intermediate term financial benefits that enable us to continue to advance the technology and fill the pipeline with more exciting new drugs," said B. Lynne Parshall, COO and CFO of Isis.

Upcoming Key Milestones

  • Report full data from a Phase 3 study evaluating mipomersen in homozygous Familial Hypercholesterolemia (FH) patients; positive top line data was reported in May 2009
  • Report data from additional mipomersen studies in othe
    '/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Medical Systems (NYSE: VAR ) today is ... the third quarter of fiscal year 2014.  Net earnings ... due to an approximately $8 million impairment charge related ... Augmenix, a privately-held company developing minimally invasive hydrogels for ... third quarter of fiscal year 2014, up 3 percent ...
(Date:7/23/2014)... 23, 2014 Research and Markets  has ... Market by Product, End-user & by Lead Type - ... http://photos.prnewswire.com/prnh/20130307/600769 ... three major segments, namely, holter monitor, resting, and stress ... at $3,683 million in 2013 and is poised to ...
(Date:7/23/2014)... , July 23, 2014  RT Oncology Services Corporation ... to join its board of directors. Mr. Mundie is ... where he works on strategic projects within the company ... Microsoft,s chief research and strategy officer. ... of RainTree, said, "Craig is a visionary technology executive. ...
Breaking Medicine Technology:Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 10Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... /PRNewswire-iReach/ -- MediGain, a national leader ... announced the release of OptimOncology, a financial analytics ... for office-based oncology practices.  This unique technology aggregates ... measurable results for oncology practices. "Drug ...
... SAN DIEGO, Jan. 4, 2012 Gen-Probe Incorporated (NASDAQ: GPRO) ... Annual J.P. Morgan Healthcare Conference in San Francisco on January ... Eastern Time).  The presentation is scheduled to be webcast live ... section of Gen-Probe,s website at www.gen-probe.com . The webcast ...
Cached Medicine Technology:MediGain Announces Release of New Oncology Analytics Solution 2Gen-Probe to Webcast Presentation at the 30th Annual J.P. Morgan Healthcare Conference 2
(Date:7/23/2014)... of Biomedical Imaging and Bioengineering will host its second ... 2014 on the NIH campus. There will be ten ... breadth of NIBIB-funded research. , WHO: ... Rhodopsins as Optical Voltage Sensor, Quyen Nguyen, Univ. ... Nerve Imaging during Surgery, ...
(Date:7/23/2014)... July 23, 2014 The American ... 2015, ATA’s twentieth annual meeting and tradeshow focused ... expected to attract over 5,000 attendees and more ... place May 3-5, 2015, in Los Angeles. , ... healthcare technology professionals from researchers, clinicians, hospital and ...
(Date:7/23/2014)... July 23, 2014 Thousands of DePuy ... forward in a federal multidistrict litigation underway in U.S. ... reports. According to an Order dated July 18th, U.S. ... for payment of a $1,000 fee for the preservation ... , Among other things, the Order noted that there ...
(Date:7/23/2014)... Calif. Fragile X syndrome ( FXS ) is ... and other behaviors on the autistic spectrum, as well ... cause of mental impairment and the most common cause ... of California, Riverside have published a study ... in FXS. Appearing online today (July 23) in the ...
(Date:7/23/2014)... The voice on the recording was low and calm ... he was infected with the human immunodeficiency virus (HIV) that causes ... thing you know I was on the floor flat on my ... hopeful when the recording ended less than 10 minutes later. “Don’t ... because it is just God setting you up for something ...
Breaking Medicine News(10 mins):Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3
... , MORRISTOWN, N.J., July 27 ... ), a leader in generic and specialty branded pharmaceuticals, announced that ... Officer, has taken a leave of absence from the Company for ... Watson, announced that R. Todd Joyce, Vice President, Corporate Controller and ...
... , , WASHINGTON, July 27 Danaher Corporation (NYSE: ... President, has decided to retire from Danaher effective as of the end ... served as an Executive Vice President since joining Danaher in 2000. ... the growth and evolution of the Danaher portfolio over the past nine ...
... , , LOS ANGELES, July 27 ... back surgery to treat herniated discs in the spine. Anyone ... knows that it can be excruciating. Since cartilage discs separate the ... a herniated disc results in extreme pain that can cause immobility. Herniated ...
... , , , ... July 27 Amgen (Nasdaq: AMGN ) reported adjusted earnings per share ... compared to $1.14 for the second quarter of 2008. Adjusted net income increased ... million in the second quarter of 2008. , , Total revenue ...
... after exercise at lower concentrations , MONDAY, July 27 ... can have a negative effect on lung function in healthy ... Standard allows for ozone concentrations of up to 75 parts ... "found that 6.6 hours exposure to mean ozone concentrations as ...
... , , , ... luncheons at the National Press Club. National Press Club events are ... cover Luncheons and Newsmakers. Events listed are subject to last-minute changes. ... To save time and avoid waiting in line, tickets can be ...
Cached Medicine News:Health News:Watson CFO Mark W. Durand to Take Leave of Absence 2Health News:Los Angeles Surgeon Dr. Rezaian - Pioneers Cutting Edge Laser Back Surgery (laserbacksurgery.com) 2Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 2Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 3Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 4Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 5Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 6Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 7Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 8Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 9Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 10Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 11Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 12Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 13Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 14Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 15Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 16Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 17Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 18Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 19Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 20Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 21Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 22Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 23Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 24Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 25Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 26Health News:Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 27Health News:'Safe' Ozone Levels May Not Be for Some 2
... These color vision tests have been designed ... the type and estimating the grade of ... measure Red, Green, Blue, Yellow. They provide ... deficiencies. Screening is accomplished using the initial ...
... The Richmond Products version of the Farnsworth ... containers which make scoring easy and reduces the ... patients disc sequence intact. ,The Farnsworth 100 Hue ... four clear Acrylic boxes, a tray, a durable ...
Gas powered, single use, reloadable, laparoscopic 15 mm linear cutting stapler for resection, transection and anastomosis with titanium staples....
... Acrylic is the newest technology available in ... lens combines exceptional material and design properties ... , Biostability , Unique foldable hydrophobic acrylic ... to be biostable , High index ...
Medicine Products: